Global Leber's Hereditary Optic Neuropathy Drug Market Study 2016-2026, by Segment (Elamipretide, GS-011, … …), by Market (Hospital, Clinic, … …), by Company (Alkeus Pharmaceuticals, Inc., Biovista Inc., … …)
SKU ID :99ST-14613252 | Published Date: 17-Oct-2019 | No. of pages: 58Description
Summary
The global Leber's Hereditary Optic Neuropathy Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Elamipretide
GS-011
IXC-201
KH-176
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital
Clinic
Others
Alkeus Pharmaceuticals, Inc.
Biovista Inc.
GenSight Biologics S.A.
Ixchel Pharma, LLC
Khondrion BV
Spark Therapeutics, Inc.
Stealth BioTherapeutics Inc
North America
Europe
Asia-Pacific
South America
Middle East & Africa
The global Leber's Hereditary Optic Neuropathy Drug market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.
Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Elamipretide
GS-011
IXC-201
KH-176
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital
Clinic
Others
Company Coverage (Sales data, Main Products & Services etc.):
Alkeus Pharmaceuticals, Inc.
Biovista Inc.
GenSight Biologics S.A.
Ixchel Pharma, LLC
Khondrion BV
Spark Therapeutics, Inc.
Stealth BioTherapeutics Inc
Major Region
MarketNorth America
Europe
Asia-Pacific
South America
Middle East & Africa
TOC
Tables & Figures
Companies
- PRICE
-
$1800$3600Buy Now